title: Effects of Payena dasyphylla (Miq.) on hyaluronidase enzyme activity and metalloproteinases protein expressions in interleukin-1β stimulated human chondrocytes cells.
abstract: BACKGROUND
  Hyaluronidases have been found as the target enzymes in the development of osteoarthritis (OA) disease. While there is still no curative treatment for this disease, recent studies on the treatment of OA were focused on the effectiveness of natural products which are expected to improve the symptoms with minimal side effects. The aim of this study was to screen selected Malaysian plants on their anti-hyaluronidase activity as well as to evaluate the active plant and its derived fractions on its potential anti-arthritic and antioxidant activities.
  
  
  METHODS
  A total of 20 methanolic crude extracts (bark and leaf) from ten different plants were screened using a colorimetric hyaluronidase enzymatic assay. The active plant extract (Payena dasyphylla) was then studied for its hyaluronidase inhibitory activity in the interleukin-1β (IL-1β) stimulated human chondrocytes cell line (NHAC-kn) using zymography method. The Payena dasyphylla methanolic bark extract was then fractionated into several fractions in where the ethyl acetate (EA) fraction was evaluated for its inhibitory effects on the HYAL1 and HYAL2 gene expressions using reverse transcription-polymerase chain reaction (RT-PCR) technique. While the MMP-3 and MMP-13 protein expressions were evaluated using western blot method. The phenolic and flavonoid contents of the three fractions as well as the antioxidant property of the EA fraction were also evaluated.
  
  
  RESULTS
  Bark extract of Payena dasyphylla (100 μg/ml) showed the highest inhibitory activity against bovine testicular hyaluronidase with 91.63%. The plant extract also inhibited hyaluronidase expression in the cultured human chondrocyte cells in response to IL-1β (100 ng/ml). Similarly, treatment with Payena dasyphylla ethyl acetate (EA) fraction (100 μg/ml) inhibited the HYAL1 and HYAL2 mRNA gene expressions as well as MMP-3 and MMP-13 protein expression in a dose dependent manner. Payena dasyphylla EA fraction has demonstrated the highest amount of phenolic and flavonoid content with 168.62 ± 10.93 mg GAE/g and 95.96 ± 2.96 mg RE/g respectively as compared to water and hexane fractions. In addition, the Payena dasyphylla EA fraction showed strong antioxidant activity with IC₅₀ value of 11.64 ± 1.69 μg/mL.
  
  
  CONCLUSIONS
  These findings have shown that Payena dasyphylla might contained potential phenolic compounds that inhibiting the key enzyme in osteoarthritis development, which is the hyaluronidase enzyme through interruption of HYAL1 and HYAL1 gene expressions. The degradation of cartilage could also be inhibited by the plant through suppression of MMP-3 and MMP-13 protein expressions. We also reported that the inhibitory effect of Payena dasyphylla on hyaluronidase activity and expression might be due to its anti-oxidant property.
authors: Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. syahida@biotech.upm.edu.my.
authors: Kamini
authors: K
authors: Citalingam
authors: Seema
authors: S
authors: Zareen
authors: Khozirah
authors: K
authors: Shaari
authors: Syahida
authors: S
authors: Ahmad
mesh_terms: D000085:Acetates; D000975:Antioxidants / Q000737:chemistry / Q000494:pharmacology; D001713:Biphenyl Compounds; D002460:Cell Line; D002478:Cells, Cultured; D019902:Chondrocytes / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism*; D005419:Flavonoids / Q000032:analysis / Q000737:chemistry; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000032:analysis / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D053583:Interleukin-1beta / Q000494:pharmacology; D045726:Metalloproteases / Q000032:analysis / Q000378:metabolism*; D000432:Methanol; D010851:Picrates; D024301:Plant Bark / Q000737:chemistry; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology*; D029632:Sapotaceae / Q000737:chemistry*
chemical_list: D000085:Acetates; D000975:Antioxidants; D001713:Biphenyl Compounds; D005419:Flavonoids; D053583:Interleukin-1beta; D010851:Picrates; D010936:Plant Extracts; C007650:ethyl acetate; C004931:1,1-diphenyl-2-picrylhydrazyl; D006821:Hyaluronoglucosaminidase; D045726:Metalloproteases; D000432:Methanol
references: Cell Mol Life Sci. 2002 Jan;59(1):45-53
references: 11846032
references: J Clin Invest. 1997 Apr 1;99(7):1534-45
references: 9119997
references: Arthritis Rheum. 2003 Dec;48(12):3395-403
references: 14673991
references: J Cell Physiol. 2007 Dec;213(3):626-34
references: 17786965
references: Cancer Lett. 1998 Sep 11;131(1):3-11
references: 9839614
references: Biochem Soc Trans. 1990 Oct;18(5):812-5
references: 2083684
references: Biochem Biophys Res Commun. 1998 Oct 29;251(3):824-9
references: 9790994
references: J Clin Invest. 1996 Nov 15;98(10):2292-9
references: 8941646
references: Prog Med Chem. 1977;14:285-301
references: 345357
references: Clin Microbiol Rev. 1999 Oct;12(4):564-82
references: 10515903
references: JAMA. 2000 Sep 13;284(10):1247-55
references: 10979111
references: Matrix. 1992 Nov;12(5):388-96
references: 1484506
references: J Clin Invest. 1989 Aug;84(2):678-85
references: 2760206
references: Ann Biomed Eng. 2010 Nov;38(11):3363-70
references: 20571855
references: Lab Invest. 1999 Dec;79(12):1669-77
references: 10616215
references: Science. 1999 Jun 4;284(5420):1664-6
references: 10356395
references: Adv Exp Med Biol. 1994;366:351-76
references: 7771265
references: Osteoarthritis Cartilage. 2006 Sep;14(9):849-58
references: 16600643
references: J Biol Chem. 1955 Dec;217(2):959-66
references: 13271455
references: Glycobiology. 2003 Dec;13(12):105R-115R
references: 14514708
references: Protein Sci. 1995 Sep;4(9):1666-9
references: 8528065
references: J Biol Chem. 1996 Sep 20;271(38):23577-81
references: 8798568
references: Rheumatology (Oxford). 2001 Jul;40(7):779-93
references: 11477283
references: Arch Oral Biol. 1998 Sep;43(9):717-28
references: 9783826
references: Med Clin North Am. 2009 Jan;93(1):45-66, x
references: 19059021
references: Arthritis Rheum. 1992 Oct;35(10):1227-33
references: 1418008
references: Arthritis Rheum. 1997 Nov;40(11):2065-74
references: 9365097
references: J Clin Invest. 1996 May 1;97(9):2011-9
references: 8621789
references: Osteoarthritis Cartilage. 2003 Oct;11(10):747-55
references: 13129694
references: J Biol Chem. 2005 Jul 22;280(29):26904-12
references: 15923194
references: J Clin Invest. 1992 Apr;89(4):1189-97
references: 1313449
references: J Biol Chem. 1996 Jan 19;271(3):1544-50
references: 8576151
references: J Clin Invest. 1996 Feb 1;97(3):761-8
references: 8609233
references: J Biol Chem. 1999 Jul 30;274(31):21491-4
references: 10419448